According to Abiomed's latest financial reports the company has $0.82 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-03-31 | $0.75 B | 29.97% |
2021-03-31 | $0.58 B | 31.73% |
2020-03-31 | $0.44 B | -9.88% |
2019-03-31 | $0.49 B | 35.73% |
2018-03-31 | $0.36 B | 57.54% |
2017-03-31 | $0.22 B | 8.44% |
2016-03-31 | $0.21 B | 60.7% |
2015-03-31 | $0.13 B | 72.32% |
2014-03-31 | $76.57 M | -0.17% |
2013-03-31 | $76.7 M | -0.67% |
2012-03-31 | $77.22 M | 28.04% |
2011-03-31 | $60.31 M | 3.51% |
2010-03-31 | $58.26 M | 1.9% |
2009-03-31 | $57.17 M | 49.3% |
2008-03-31 | $38.29 M | -49.02% |
2007-03-31 | $75.12 M | 143.64% |
2006-03-31 | $30.83 M | -25.71% |
2005-03-31 | $41.5 M | 51.89% |
2004-03-31 | $27.32 M | -49.82% |
2003-03-31 | $54.44 M | -23.66% |
2002-03-31 | $71.32 M | -22.89% |
2001-03-31 | $92.49 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
Boston Scientific BSX | $0.86 B | 5.44% | ๐บ๐ธ USA |
Teleflex TFX | $0.22 B | -72.84% | ๐บ๐ธ USA |
AtriCure ATRC | $0.13 B | -83.27% | ๐บ๐ธ USA |